The association of methadone use with physical function and frailty among persons who inject drugs.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: The association of methadone use with physical function and frailty among persons who inject drugs.
Συγγραφείς: Kulik GL; Division of Infectious Diseases, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA., Hsu HY; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Rudolph J; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Jiang Y; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Erlandson KM; Division of Infectious Diseases, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA., Piggott DA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD, USA., Mehta S; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Walston JD; Division of Gerontology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Kirk G; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD, USA., Brown TT; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Division of Endocrinology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Sun J; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Πηγή: Addiction (Abingdon, England) [Addiction] 2026 May; Vol. 121 (5), pp. 1217-1226. Date of Electronic Publication: 2025 Dec 24.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1360-0443 (Electronic) Linking ISSN: 09652140 NLM ISO Abbreviation: Addiction Subsets: MEDLINE
Imprint Name(s): Publication: Oxford : Wiley-Blackwell
Original Publication: Abingdon, Oxfordshire, UK : Carfax Pub. Co., c1993-
Ιατρικοί όροι (MeSH): Methadone*/therapeutic use , Methadone*/adverse effects , Frailty*/epidemiology , Substance Abuse, Intravenous*/drug therapy , Substance Abuse, Intravenous*/epidemiology , Opioid-Related Disorders*/drug therapy, Baltimore/epidemiology ; Humans ; Female ; Male ; Adult ; Retrospective Studies ; Middle Aged ; Longitudinal Studies ; Opiate Substitution Treatment ; Hand Strength
Περίληψη: Background and Aims: Persons who inject drugs (PWID) experience a high burden of early-onset frailty, primarily due to multifactorial causes such as infections (human immunodeficiency virus [HIV], hepatitis C virus [HCV]), substance use, and polypharmacy. Methadone, although an effective treatment for opioid use disorder, has demonstrated toxicity across several body systems that may impact or accelerate the aging process. Therefore, the purpose of this analysis was to determine the association of methadone use with frailty and physical function among PWID.
Design: This study performed a retrospective analysis from the AIDS Linked to IntraVenous Experience (ALIVE) longitudinal cohort between 2005 and 2020, using multivariable mixed effect logistic regression, adjusting for demographics, body mass index, substance use, HIV, and comorbidities.
Setting: Baltimore, Maryland, United States.
Participants: Adult participants (≥18 years) were recruited into the ALIVE cohort if they reported a history of or current injection drug use. Our study included 2153 participants with 13 909 person-years of follow-up.
Measurements: Methadone usage, whether prescribed or non-medical, was self-reported by participants during study follow-up. The primary outcome measurement was frailty as defined by the Fried frailty phenotype. Physical function was measured using grip strength and 4-m gait speed.
Findings: At baseline, 883 were currently using methadone. Median age was 48 (interquartile range: 42, 53) years; 81% were Black, 34% female, 80% had incomes <$5000, and 31% were living with HIV. Methadone use was associated with 25% higher odds of frailty (95% confidence interval [CI]: 1.09, 1.43). This difference suggested that the odds of frailty among individuals using methadone at age 50 were comparable to those not using methadone at age 54. Methadone use was associated with lower average grip strength [-0.71 kg (95% CI: -0.94, -0.48)], but not slower gait speed.
Conclusions: Among persons who inject drugs, those using methadone appear to be more likely to experience frailty at an earlier age compared with those not using methadone. Early screening for frailty and other geriatric conditions may be warranted among individuals with active methadone use in this population.
(© 2025 The Author(s). Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.)
References: Volkow ND, Blanco C. The changing opioid crisis: development, challenges and opportunities. Mol Psychiatry. 2021;26(1):218–233. https://doi.org/10.1038/s41380-020-0661-4.
Spencer, MR MA, Warner, M. Drug overdose deaths in the united states, 2001–2021 NCHS Data Brief, no 457. Hyattsville, MD: National Center for Health Statistics. 2022.
Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, et al. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study. Ann Intern Med. 2018;169(3):137–145. https://doi.org/10.7326/M17-3107.
Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta‐analysis of cohort studies. Addiction. 2011;106(1):32–51. https://doi.org/10.1111/j.1360-0443.2010.03140.x.
Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet. 1999;353(9148):221–226. https://doi.org/10.1016/S0140-6736(98)05356-2.
Karki P, Shrestha R, Huedo‐Medina TB, Copenhaver M. The impact of methadone maintenance treatment on HIV risk behaviors among high‐risk injection drug users: A systematic review. Evid‐based med publ health. 2016;2:e1229.
Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000;59(1):17–31. https://doi.org/10.1016/S0376-8716(99)00104-0.
Salleh NM, Voon P, Karamouzian M, Milloy M, Richardson L. Methadone maintenance therapy service components linked to improvements in HIV care cascade outcomes: A systematic review of trials and observational studies. Drug Alcohol Depend. 2021;218:108342.
Han B, Polydorou S, Ferris R, Blaum CS, Ross S, McNeely J. Demographic trends of adults in New York City opioid treatment programs‐‐an aging population. Subst Use Misuse. 2015;50(13):1660–1667. https://doi.org/10.3109/10826084.2015.1027929.
Arnold‐Reed DE, Brett T, Troeung L, O'Neill J, Backhouse R, Bulsara MK. Multimorbidity in patients enrolled in a community‐based methadone maintenance treatment programme delivered through primary care. J Comorb. 2014;4(1):46–54. https://doi.org/10.15256/joc.2014.4.42.
O'Toole J, Hambly R, Cox AM, O'Shea B, Darker C. Methadone‐maintained patients in primary care have higher rates of chronic disease and multimorbidity, and use health services more intensively than matched controls. Eur J Gen Pract. 2014;20(4):275–280. https://doi.org/10.3109/13814788.2014.905912.
Reece AS. Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers. Immun Ageing. 2007;4(1):6. https://doi.org/10.1186/1742-4933-4-6.
Han BH, Cotton BP, Polydorou S, Sherman SE, Ferris R, Arcila‐Mesa M, et al. Geriatric Conditions Among Middle‐aged and Older Adults on Methadone Maintenance Treatment: A Pilot Study. J Addict Med. 2022;16(1):110–113. https://doi.org/10.1097/ADM.0000000000000808.
Piggott DA, Muzaale AD, Varadhan R, Mehta SH, Westergaard RP, Brown TT, et al. Frailty and Cause‐Specific Hospitalization Among Persons Aging With HIV Infection and Injection Drug Use. J Gerontol A Biol Sci Med Sci. 2017;72(3):389–394. https://doi.org/10.1093/gerona/glw142.
Piggott DA, Muzaale AD, Mehta SH, Brown TT, Patel KV, Leng SX, et al. Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS ONE. 2013;8(1):e54910. https://doi.org/10.1371/journal.pone.0054910.
Li W, Li Q, Wang Y, Zhu J, Ye J, Yan X, et al. Methadone‐induced Damage to White Matter Integrity in Methadone Maintenance Patients: A Longitudinal Self‐control DTI Study. Sci Rep. 2016;6(1):19662. https://doi.org/10.1038/srep19662.
Hassamal S, Fernandez A, Moradi Rekabdarkolaee H, Pandurangi A. QTc Prolongation in Veterans With Heroin Dependence on Methadone Maintenance Treatment. Int J High Risk Behav Addict. 2015;4(2):e23819. https://doi.org/10.5812/ijhrba.4(2)2015.23819.
Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, Celentano DD, et al. The ALIVE study, a longitudinal study of HIV‐1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr. 1991;109:75–100.
Reinert DF, Allen JP. The alcohol use disorders identification test (AUDIT): a review of recent research. Alcohol Clin Exp Res. 2002;26(2):272–279. https://doi.org/10.1111/j.1530-0277.2002.tb02534.x.
Trampisch US, Franke J, Jedamzik N, Hinrichs T, Platen P. Optimal Jamar dynamometer handle position to assess maximal isometric hand grip strength in epidemiological studies. J Hand Surg Am. 2012;37(11):2368–2373. https://doi.org/10.1016/j.jhsa.2012.08.014.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–M156. https://doi.org/10.1093/gerona/56.3.m146.
Vallecillo GPR, Durán X, Canosa I, Roquer A, Martinez M, Robles M. Prevalence and associated factors of frailty in a cohort of older people with opioid use disorder receiving opioid agonist therapy. Int Journal of Geriatric Gerontology. 2024;8:179.
Bobos P, Nazari G, Lu Z, MacDermid JC. Measurement properties of the hand grip strength assessment: A systematic review with meta‐analysis. Arch Phys Med Rehabil. 2020;101(3):553–565. https://doi.org/10.1016/j.apmr.2019.10.183.
Piggott DA, Varadhan R, Mehta SH, Brown TT, Li H, Walston JD, et al. Frailty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use. J Gerontol A Biol Sci Med Sci. 2015;70(12):1542–1547. https://doi.org/10.1093/gerona/glv107.
Vuong C, Van Uum SH, O'Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev. 2010;31(1):98–132. https://doi.org/10.1210/er.2009-0009.
Duarte RV, Raphael JH, Southall JL, Labib MH, Whallett AJ, Ashford RL. Hypogonadism and low bone mineral density in patients on long‐term intrathecal opioid delivery therapy. BMJ Open. 2013;3(6):e002856. https://doi.org/10.1136/bmjopen-2013-002856.
Fortin JD, Bailey GM, Vilensky JA. Does opioid use for pain management warrant routine bone mass density screening in men? Pain Physician. 2008;11(4):539–541. https://doi.org/10.36076/ppj.2008/11/539.
Greco EA, Pietschmann P, Migliaccio S. Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly. Front Endocrinol (Lausanne). 2019;10:255. https://doi.org/10.3389/fendo.2019.00255.
Cesari M, Leeuwenburgh C, Lauretani F, et al. Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. Am J Clin Nutr. 2006;83(5):1142–1148. https://doi.org/10.1093/ajcn/83.5.1142.
Hendry A, Vanhecke E, Carriazo AM, López‐Samaniego L, Espinosa JM, Sezgin D, et al. Integrated Care Models for Managing and Preventing Frailty: A Systematic Review for the European Joint Action on Frailty Prevention (ADVANTAGE JA). Transl Med UniSa. 2019;19:5–10.
Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmüller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab. 2005;90(1):203–206. https://doi.org/10.1210/jc.2004-0929.
Twisk J, de Vente W. Attrition in longitudinal studies. How to deal with missing data. J Clin Epidemiol. 2002;55(4):329–337. https://doi.org/10.1016/s0895-4356(01)00476-0.
Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7(2):147–177. https://doi.org/10.1037/1082-989X.7.2.147.
Laird NM, Ware JH. Random‐effects models for longitudinal data. Biometrics. 1982;38(4):963–974. https://doi.org/10.2307/2529876.
Chakraborty H, Gu H. RTI Press Methods Report Series. In: A Mixed Model Approach for Intent‐to‐Treat Analysis in Longitudinal Clinical Trials with Missing Values Research Triangle Park (NC): RTI Press © 2009 Research Triangle Institute. All rights reserved; 2009.
Rodríguez‐Mañas L, Féart C, Mann G, Viña J, Chatterji S, Chodzko‐Zajko W, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition‐consensus conference project. J Gerontol A Biol Sci Med Sci. 2013;68(1):62–67. https://doi.org/10.1093/gerona/gls119.
Bouillon K, Kivimaki M, Hamer M, Sabia S, Fransson EI, Singh‐Manoux A, et al. Measures of frailty in population‐based studies: an overview. BMC Geriatr. 2013;13(1):64. https://doi.org/10.1186/1471-2318-13-64.
Grant Information: K12HL143957 United States HL NHLBI NIH HHS; K24AG082527 United States AG NIA NIH HHS; K01 AI162247 United States AI NIAID NIH HHS; P30 AG021334 United States AG NIA NIH HHS; K01AI162247 National Institute of Allergy and Infectious Diseases; K24 AG082527 United States AG NIA NIH HHS; U01DA036297 United States DA NIDA NIH HHS; K24AI120834 National Institute of Allergy and Infectious Diseases; T32AI150547 National Institute of Allergy and Infectious Diseases
Contributed Indexing: Keywords: aging; frailty; functional impairment; methadone; opioid agonist therapy; persons who inject drugs; physical function
Substance Nomenclature: UC6VBE7V1Z (Methadone)
Entry Date(s): Date Created: 20251224 Date Completed: 20260417 Latest Revision: 20260517
Update Code: 20260517
PubMed Central ID: PMC13088933
DOI: 10.1111/add.70306
PMID: 41437797
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1360-0443
DOI:10.1111/add.70306